Document is current

Article History

Received: 22 July 2024

Accepted: 3 September 2024

First Online: 9 October 2024

Declarations

:

: Gilberto Castañeda-Hernández reports receiving an honorarium from the American Health Foundation, payments to his institution from CONAHCYT, consulting fees from Laboratorios Sophia, payments from Pfizer, Sandoz, and Amgen, and non-payment leadership role in Biored CAC. Manuel Antonio Espinoza reports receiving an honorarium from AHF, grants or contracts to his department from World Bank, research grants from ANID FONIS SA19101882220002, ANID FONDAP152220002, consulting fees from Interamerican Bank of Development, World Bank, and Center for Global Development, payment or honoraria from Merck, MSD, Grunenthal, Novartis, Abbvie, Boehringer Ingelheim, and Roche, support for meeting attendance from ISPOR and HTAI, participation on advisory boards for Merck, Novartis, and Biomarin. Luis Eduardo Pino reports receiving an honorarium from AHF, consulting fees from Sanofi, AstraZeneca, and Janssen, honoraria from Roche, AstraZeneca, Janssen, and Novartis, and participating in advisory boards for Janssen and Knight Therapeutics, and owning stock in OxLER SAS. Mariana Rico-Restrepo reports that her institution received an unrestricted grant from Abbott. Bianca Schiavetti reports receiving an honorarium from AHF, consulting fees from Abbvie, Amgen, Ferring, Fresenius, Janssen, Organon, and Takeda, payments for presentations and meeting support from Abbvie, Amgen, Celltrion, Ferring, Fresenius, Janssen, Organon, Pfizer, Sandoz, and Takeda, receipt of equipment from Bühlmann and Celltrion. Enrique Teran reports speaker honoraria from Abbott, Bayer, Janssen, Heel, Medicamenta, Merck, MSD, Novartis, Pfizer, Roche and Sanofi. Valderilio Feijó Azevedo reports receiving an honorarium from the American Health Foundation.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.